Wikipedia

User:Mr. Ibrahem/Janssen COVID-19 vaccine

< User:Mr. Ibrahem
"Johnson & Johnson vaccine" and "Johnson & Johnson COVID-19 vaccine" redirect here. For other J&J vaccination topics, see Janssen Vaccines.

Mr. Ibrahem/Janssen COVID-19 vaccine
A vial of Janssen COVID-19 vaccine
Vaccine description
TargetSARS-CoV-2
Vaccine typeViral vector
Clinical data
Trade namesJanssen COVID-19 Vaccine,[1][2] COVID-19 Vaccine Janssen[3][4]
Other namesJohnson & Johnson COVID-19 vaccine
AHFS/Drugs.comMonograph
License data
Pregnancy
category
Routes of
administration		Intramuscular
Drug classCOVID-19 vaccine[4]
Legal status
Legal status
Full list of Janssen vaccine authorizations

Janssen COVID-19 vaccine is a COVID-19 vaccine.[4] It is used in people over the age of 17 to prevent COVID-19.[4] It is given by injection into a muscle.[4] A second dose may be given 2 months after the first.[4] The initial trials found that it decreases the risk of COVID-19 after 2 weeks by 67% and severe disease by 77%.[4][1]

Most side effects are mild to moderate and resolve within a few days.[4] These may include injection site pain, headache, tiredness, muscle pain, and nausea.[4] Rare side effects may include blood clots, Guillain-Barré syndrome, low platelets, and anaphylaxis.[4] There is no evidence of harm with use in pregnancy.[24] It is a viral vector vaccine, meaning that it is made up of another virus (adenovirus) that has been modified to contain the gene for making the spike protein of the SARS-CoV-2 virus.[4]

The vaccine received emergency use authorization (EUA) in the United States in February 2021 and was approved for medical use in Europe in March 2021.[24][4] It has been authorized for use at some level in at least 82 countries as of 2022.[25] It was developed by Janssen Vaccines in the Netherlands,[26] and its Belgian parent company Janssen Pharmaceuticals,[27] a subsidiary of American company Johnson & Johnson.[26] The US government paid about 10 USD per dose and provides them for free.[28][29] The vaccine is stored refrigerated rather than frozen.[24]

References edit

  1. ^ a b c "Janssen COVID-19 Vaccine – ad26.cov2.s injection, suspension". DailyMed. U.S. National Institutes of Health. Archived from the original on 12 May 2021. Retrieved 27 February 2021.
  2. ^ "Janssen COVID-19 Emergency Use Authorization (EUA) Official Website". Janssen. 28 February 2021. Archived from the original on 1 March 2021. Retrieved 28 February 2021.
  3. ^ Cite error: The named reference Janssen CMA application was invoked but never defined (see the help page).
  4. ^ a b c d e f g h i j k l m n o "COVID-19 Vaccine Janssen EPAR". European Medicines Agency (EMA). 5 March 2021. Archived from the original on 15 March 2021. Retrieved 16 March 2021. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
  5. ^ a b "COVID-19 Vaccine Janssen". Therapeutic Goods Administration (TGA). 25 June 2021. Archived from the original on 28 August 2021. Retrieved 28 August 2021.
  6. ^ Cite error: The named reference TGA provisional approval was invoked but never defined (see the help page).
  7. ^ "Archive copy". Archived from the original on 28 August 2021. Retrieved 14 March 2022.{{cite web}}: CS1 maint: archived copy as title (link)
  8. ^ "TGA grants third provisional approval to COVID-19 vaccine: Janssen". Therapeutic Goods Administration (TGA). 25 June 2021. Archived from the original on 14 October 2021. Retrieved 22 October 2021.
  9. ^ "Brazil health regulator approves emergency use of Johnson & Johnson COVID-19 vaccine". Rio de Janeiro: Reuters. 31 March 2021. Archived from the original on 30 January 2022. Retrieved 1 April 2021.
  10. ^ "Anvisa aprova uso emergencial da vacina da Janssen" [Anvisa approves emergency use of Janssen vaccine] (in Portuguese). Federal government of Brazil. Brazilian Health Regulatory Agency. 31 March 2021. Archived from the original on 20 November 2021. Retrieved 20 November 2021.
  11. ^ "Janssen (Johnson & Johnson) COVID-19 vaccine". Health Canada. 5 March 2021. Archived from the original on 23 November 2021. Retrieved 24 November 2021.
  12. ^ Cite error: The named reference CA Regulatory Decision Summary was invoked but never defined (see the help page).
  13. ^ "Regulatory Decision Summary – Janssen COVID-19 Vaccine – Health Canada". Health Canada. 5 March 2021. Archived from the original on 5 March 2021. Retrieved 5 March 2021.
  14. ^ "Janssen COVID-19 Vaccine monograph" (PDF). Janssen. 5 March 2021. Archived (PDF) from the original on 5 March 2021. Retrieved 5 March 2021.
  15. ^ "Regulatory approval of COVID-19 Vaccine Janssen". Medicines and Healthcare products Regulatory Agency (MHRA). 28 May 2021. Archived from the original on 28 May 2021. Retrieved 29 May 2021.
  16. ^ "One-dose Janssen COVID-19 vaccine approved by the MHRA" (Press release). Medicines and Healthcare products Regulatory Agency (MHRA). 28 May 2021. Archived from the original on 28 May 2021. Retrieved 29 May 2021.
  17. ^ "Summary of Product Characteristics for COVID-19 Vaccine Janssen". Medicines and Healthcare products Regulatory Agency (MHRA). 28 May 2021. Archived from the original on 28 May 2021. Retrieved 29 May 2021.
  18. ^ "FDA Issues Emergency Use Authorization for Third COVID-19 Vaccine". U.S. Food and Drug Administration (FDA) (Press release). 27 February 2021. Archived from the original on 18 March 2021. Retrieved 27 February 2021.
  19. ^ "FDA Letter of Authorization" (PDF). Food and Drug Administration. 27 February 2021. Archived from the original on 10 March 2021. Retrieved 28 February 2021. ...letter is in response to a request from Janssen Biotech, Inc. that the Food and Drug Administration (FDA) issue an Emergency Use Authorization (EUA)...
  20. ^ Cite error: The named reference FDA Janssen COVID-19 Vaccine was invoked but never defined (see the help page).
  21. ^ "Janssen COVID-19 Vaccine (Johnson & Johnson) Standing Orders for Administering Vaccine to Persons 18 Years of Age and Older" (PDF). U.S. Centers for Disease Control and Prevention (CDC). Archived (PDF) from the original on 16 April 2021. Retrieved 16 April 2021.
  22. ^ "Johnson & Johnson Covid vaccine approved for general use in South Africa". Archived from the original on 9 May 2021. Retrieved 9 May 2021.
  23. ^ "J&J Covid-19 Vaccine Approved in South Africa for Wider Use". Bloomberg.com. 1 April 2021. Archived from the original on 9 April 2021. Retrieved 9 May 2021.
  24. ^ a b c "COVID-19 Vaccine (Janssen) Monograph for Professionals". Drugs.com. Retrieved 29 January 2022.
  25. ^ Holder, Josh (29 January 2021). "Tracking Coronavirus Vaccinations Around the World". The New York Times. Archived from the original on 22 December 2021. Retrieved 28 January 2022.
  26. ^ a b "Leiden developed Covid-19 vaccine submitted to EMA for approval". 16 February 2021. Archived from the original on 25 June 2021. Retrieved 15 March 2021.
  27. ^ "Clinical trial COVID-19 vaccine candidate underway". Janssen Belgium. Archived from the original on 15 January 2021. Retrieved 13 March 2021.
  28. ^ "COVID-19 Vaccination". Centers for Disease Control and Prevention. 11 February 2020. Archived from the original on 28 January 2022. Retrieved 29 January 2022.
  29. ^ "Here's How Much COVID-19 Vaccines Will Cost From The 5 Frontrunners". Observer. 5 August 2020. Archived from the original on 10 September 2021. Retrieved 29 January 2022.
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Mr._Ibrahem/Janssen_COVID-19_vaccine&oldid=1152917644"